The sensitivity analysis results suggested that after patients with elevated ALT and/or AST levels were excluded, the associations between the liver fibrosis scores and ASCVD remained relatively stable, thus highlighting the important notion that even individuals with normal aminotransferase levels should not underestimate the risk of liver fibrosis and the accompanying ASCVD risk. This evidence concerns the gene GPT and Hepatic fibrosis.